Directorate Change

Company Announcement                              

27 July 2006

SPECTRIS PLC

Spectris plc is pleased to announce that Peter Chambré will be joining the
board as a non-executive director on 1st August 2006. Peter was until very
recently Chief Executive Officer of Cambridge Antibody Technology Group plc and
previously was Chief Operating Officer of Celera Genomics Group and Chief
Executive of Bespak plc.

There are no further details to be disclosed in respect of Listing Rule
9.6.13R.

Roger Stephens

Company Secretary

Spectris plc

01784 470470